Welcome to our dedicated page for Omada Health SEC filings (Ticker: OMDA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Omada Health, Inc. (Nasdaq: OMDA) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. As a virtual-first, between-visit healthcare provider focused on cardiometabolic and musculoskeletal conditions, Omada uses these filings to report on its financial condition, operations, and material events related to its digital chronic care platform.
Investors can review current reports on Form 8-K, which Omada uses to furnish press releases announcing quarterly results and other significant developments. For example, recent 8-K filings reference earnings press releases for periods in which the company reported revenue, member growth, and updates on its GLP-1-related offerings and AI capabilities. These current reports help readers connect headline financial and operational metrics to the underlying SEC record.
In addition to 8-Ks, Omada’s periodic reports on Form 10-Q and Form 10-K (accessible through the SEC and linked from this page when available) typically contain more detailed information on revenue composition, cost structure, research and development spending, and risks associated with its virtual care and GLP-1 programs. These filings are particularly relevant for understanding how Omada’s cardiometabolic and musculoskeletal programs, GLP-1 Care Tracks, and prescribing and medication management capabilities are reflected in its financial statements and risk disclosures.
Stock Titan enhances this information with AI-powered summaries that explain key points from lengthy filings, helping readers quickly identify sections related to Omada’s chronic care model, GLP-1 initiatives, and digital health operations. Users can also monitor updates to OMDA’s filings in near real time, including new 8-Ks, 10-Qs, 10-Ks, and other relevant forms, to follow how the company reports on its performance and material events over time.
Omada Health, Inc. (OMDA) reported that Chief Executive Officer and director Sean P. Duffy sold a total of 14,960 shares of common stock on September 10, 2026 in open-market transactions made pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2026. The filing also reports 851,659 shares of common stock held indirectly in family trusts for the benefit of his family members, for which he disclaims beneficial ownership except to the extent of his pecuniary interest.
Omada Health, Inc. (OMDA) reported that its Chief Financial Officer, Steven L. Cook, sold a total of 6,800 shares of Common Stock on September 10, 2026, in open-market or private transactions under a Rule 10b5-1 trading plan adopted on March 14, 2026.
The sales consisted of 6,200 shares at a weighted average price of $21.80 (with individual trade prices between $21.38 and $22.35) and 600 shares at a weighted average price of $22.52 (with trade prices between $22.41 and $22.75). Post-transaction share holdings are not reported in this filing.
Omada Health, Inc. (OMDA) reported that President Wei-Li Shao sold a total of 4,036 shares of common stock on September 10, 2026. The sales were made in open market or private transactions at weighted average prices of $21.78 for 3,636 shares and $22.53 for 400 shares, pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2026.
Omada Health, Inc. (OMDA) reported that its Chief Accounting Officer, Gracey Craig, sold 644 shares of common stock on September 9, 2026 at a weighted average price of $21.73 per share in an open-market or private transaction. The sale was made pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2026, and left her with 14,412 shares of common stock held directly.
Omada Health, Inc. (OMDA) is named as the issuer in a Form 144 filed for proposed sales of common stock by officer Steven Cook. The notice covers up to 6,800 shares of common stock, with an estimated aggregate market value of $146,200.00, to be sold through Morgan Stanley Smith Barney LLC on NASDAQ. The shares were acquired upon vesting of restricted stock units during the period from September 1, 2026 through September 5, 2026. The notice also lists multiple prior common stock sales during the preceding three months that are identified as Rule 10b5-1 sales.
Omada Health, Inc. (OMDA) received a notice that stockholder Wei-Li Shao intends to sell up to 4,036 shares of common stock under Rule 144 through Morgan Stanley Smith Barney LLC. The shares were acquired upon vesting of restricted stock units during the period from September 1, 2026 through September 5, 2026.
The notice also lists prior Rule 10b5-1 sales of Omada Health common stock for this holder over the preceding three months, including 9,418 shares sold on August 12, 2026 and 4,037 shares sold on June 12, 2026.
Omada Health, Inc. (OMDA) received a notice under Rule 144 that Sean Duffy intends to sell up to 14,960 shares of common stock through Morgan Stanley Smith Barney LLC, with an indicated aggregate sale price of $321,640.00 on or about September 10, 2026.
The shares come from restricted stock units that vested during the period of September 1, 2026 through September 5, 2026. The filing also lists multiple prior 10b5-1 plan sales of Omada common stock by Sean Duffy over the preceding three months, each with its own share count and dollar amount.
Omada Health, Inc. (OMDA) reported that President Wei-Li Shao had 1,843 shares of common stock disposed of on September 5, 2026 to pay the exercise price or related tax liability by delivering or having shares withheld at $22.77 per share. After this administrative disposition, Shao directly holds 299,349 shares of Omada Health common stock, and no Rule 10b5-1 trading plan is reported.
Omada Health, Inc. (OMDA) reported that its Chief Financial Officer, Steven L. Cook, had 2,010 shares of common stock disposed of on September 5, 2026 as a payment of exercise price or tax liability by delivering or withholding securities at a reference price of $22.77 per share. Following this transaction, he holds 180,706 common shares directly, and no Rule 10b5-1 trading plan is reported.
Omada Health, Inc. (OMDA) reported that Chief Executive Officer Sean P. Duffy had 4,422 shares of common stock delivered or withheld on September 5, 2026 to satisfy exercise price or tax liability at $22.77 per share. Following this transaction, he held 397,554 shares directly and 851,659 shares indirectly through family trusts, for which he disclaims beneficial ownership except to the extent of his pecuniary interest. No Rule 10b5-1 trading plan is reported.